WASHINGTON: The malaria drug promoted by US President Donald Trump as a treatment for COVID-19 was ineffective in preventing infection in people ...
WASHINGTON: The malaria drug promoted by US President Donald Trump as a treatment for COVID-19 was ineffective in preventing infection in people exposed to the coronavirus, according to a widely anticipated clinical trial released on Wednesday .AdvertisementVocal support from Trump kicked off a heated debate and raised expectations for the decades-old drug that could be a cheap and widely available tool in fighting the pandemic that has infected 6.
All participants were randomly assigned to receive either hydroxychloroquine - which is certified for use against malaria, rheumatoid arthritis and lupus - or a placebo, within four days. Several trials of the drug have been stopped over concerns about its safety for treating COVID-19 that were raised by health regulators and previous less rigorous studies."I think both sides - one side who is saying 'this is a dangerous drug' and the other side that says 'this works' - neither is correct," said Boulware.
Hydroxychloroquine - which has anti-inflammatory and antiviral properties - inhibited the virus in laboratory experiments. But these type of human trials are needed to definitively demonstrate whether the drug's benefits, if any, outweigh the risks when compared with a placebo. On Tuesday, the British medical journal the Lancet said it had concerns about data behind an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients, a conclusion that undercut scientific interest in the medicine.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Malaria drug hydroxychloroquine fails to prevent COVID-19 in high profile studyWASHINGTON, DC: The malaria drug promoted by US President Donald Trump as a treatment for COVID-19 was ineffective in preventing infection in ...
Read more »
Global COVID-19 deaths reach 375,000 as Latin America strugglesRIO DE JANEIRO: The global death toll from the coronavirus topped 375,000 on Tuesday (Jun 2) as the disease continued to tear through Latin ...
Read more »
South Korea expects human trials of Celltrion's potential COVID-19 treatment in EuropeSouth Korea expects clinical trials of Celltrion Inc's experimental COVID-19 treatment to begin in Europe next month and aims to secure sizable ...
Read more »
UK government faces mockery over COVID-19 'sex ban'LONDON: British Prime Minister Boris Johnson's government faced widespread mockery on Tuesday (Jun 2) over coronavirus rules which were cast by ...
Read more »
New COVID-19 cases in Hong Kong raise concerns of local clusterA cluster of nine coronavirus cases raised concerns in Hong Kong over renewed local transmission in a city that has been one of the most ...
Read more »
Drive-through Covid-19 swab test facility launched at One Farrer HotelGleneagles, Mount Elizabeth and Parkway East hospitals had also been trialled for the installation of drive-throughs.. Read more at straitstimes.com.
Read more »